Kyle A. Noonan, PharmD, MS is a Manager within the US Value and Access Strategy team at Cencora. In this role, he supports both scientific and commercial consulting engagements that help manufacturers prove the clinical and economic value of their products to promote favorable patient access to life-changing therapies. His work includes outcomes research strategy, pre-approval information exchange & payer value proposition development, primary market research, pricing research, and brand/market access strategy. Dr. Noonan’s expertise ranges several therapeutic areas including cardiology, neurology, dermatology, immunology, rare diseases, and across disease states in the cell & gene therapy arena.

Prior to joining Cencora, Dr. Noonan gained experience in a variety of healthcare settings, including medical affairs experience within the biopharmaceutical industry, student rotations in association management, consulting, and clinical trial research. Dr. Noonan also has extensive regional and national leadership experience with the Academy of Managed Care Pharmacy (AMCP), in addition to presenting numerous posters at AMCP conferences.

Dr. Noonan received his Doctor of Pharmacy from Mercer University, where he was recipient of the Viatris Excellence in Pharmacy Award. Dr. Noonan also received his Master of Science in Pharmaceutical Outcomes and Policy with focus in Pharmacoeconomics from the University of Florida.